Advertisement

Ads Placeholder
Loading...

Innoviva, Inc.

INVANASDAQ
Healthcare
Biotechnology
$22.99
$-0.42(-1.79%)
U.S. Market opens in 50h 45m

Innoviva, Inc. (INVA) Stock Overview

Explore Innoviva, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.5B
P/E Ratio6.34
EPS (TTM)$3.30
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$21.89
3 Months$24.76
1 Year Target$22.83

INVA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Innoviva, Inc. (INVA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.10, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.83.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 6.34 and a market capitalization of 1.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.79%
5-Day Change
1.23%
1-Month Change
3.09%
3-Month Change
15.70%
6-Month Change
31.52%
Year-to-Date (YTD) Change
15.70%
1-Year Change
27.16%
3-Year Change
101.84%
5-Year Change
86.91%
All-Time (Max) Change
69.51%

Contact Information

650 238 9600
1350 Old Bayshore Highway, Burlingame, CA, 94010

Company Facts

1,270 Employees
IPO DateOct 5, 2004
CountryUS
Actively Trading

Frequently Asked Questions